Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc.

Date Founded



230 Constitution Drive, Menlo Park, CA, 94025, USA

Type of Company


Employees (Worldwide)




Company Description

Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. The company is also focused on developing therapies to treat conditions with unmet medical needs and inadequate available therapies, with an initial focus on the therapeutic areas of oncology and neurology. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA.

Contact Data
Trying to get in touch with decision makers at Asterias Biotherapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer, Secretary & General Counsel

Chief Financial Officer & Director

Chief Medical Officer

Vice President & Controller

Senior Vice President, Research & Product Development

Senior Vice President of Research & Nonclinical Development

Vice President, Quality

Vice President-Corporate Development

Vice President-Manufacturing

Paths to Asterias Biotherapeutics, Inc.
Potential Connections via
Relationship Science
Asterias Biotherapeutics, Inc.
Recent Transactions
Details Hidden

BioTime Inc. purchases Asterias Biotherapeutics, Inc.

Details Hidden

Asterias Biotherapeutics, Inc. issued USD Units Consisting of Common Stock and Warrants

Details Hidden

Asterias Biotherapeutics, Inc. raised money in a private placement transaction

Transaction Advisors

Advised onAsterias Biotherapeutics, Inc. issued USD Units Consisting of Common Stock and Warrants

Escrow Agent

Advised onAsterias Biotherapeutics, Inc. issued USD Units Consisting of Common Stock and Warrants


Advised onAsterias Biotherapeutics, Inc. issued USD Units Consisting of Common Stock and Warrants

Legal Advisor

Advised onBioTime Inc. purchases Asterias Biotherapeutics, Inc.

Legal Advisor

Advised onBioTime Inc. purchases Asterias Biotherapeutics, Inc.

Advisors & Consultants

Former Chief Scientific Officer & Senior Vice President at Geron Corp.


Former Executive Vice President & Chief Operating Officer at Asterias Biotherapeutics, Inc.


Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

The California Institute for Regenerative Medicine ("The Institute" or "CIRM") was established in early 2005 following the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters on November 2, 2004, and called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities. The mission of CIRM is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury.

Key Stats and Financials As of 2017
Market Capitalization
Total Enterprise Value
Earnings Per Share
Details Hidden

Chairman & Chief Executive Officer at ChemioCare USA, Inc.

University of California Investment Services & Portfolio Management

The University is governed by The Regents, which under Article IX, Section 9 of the California Constitution has "full powers of organization and governance" subject only to very specific areas of legislative control. The article states that "the university shall be entirely independent of all political and sectarian influence and kept free therefrom in the appointment of its Regents and in the administration of its affairs." Board Membership Article IX, Section 9 was drafted in 1878 after a decade of political conflict demonstrated the importance of sheltering the university from shifting political winds. The board consists of 26 members: 18 regents are appointed by the governor for 12-year terms One is a student appointed by the Regents to a one-year term Seven are ex officio members -- the Governor, Lieutenant Governor, Speaker of the Assembly, Superintendent of Public Instruction, president and vice president of the Alumni Associations of UC and the UC president. In addition, two faculty members -- the chair and vice chair of the Academic Council -- sit on the board as non-voting members. Board Officers The Governor is officially the president of the Board of Regents; however, in practice the presiding officer of the Regents is the Chairman of the Board, elected from among its body for a one-year term, beginning July 1. The current Chairman is Regent Sherry Lansing. The Vice Chairman is Regent Bruce Varner. The Regents appoints Officers of The Regents: the General Counsel; the Chief Investment Officer; the Secretary and Chief of Staff; and the Chief Compliance and Audit Officer. Former Regents Here is a list of individuals who have served as Regents of the University of California: Former Regents Committees and Meetings The Regents operates through 10 standing committees: Compliance and Audit, Compensation, Educational Policy, Finance, Governance, Grounds and Buildings, Health Services, Investments, Long Range Planning, and Oversight of the Department of Energy Laboratories. The Regents meets six times a year every other month in two-day meetings

Wisconsin Alumni Research Foundation Other Business & Consulting Services | Madison, Wisconsin

Since its founding in 1925, WARF has served the University of Wisconsin-Madison scientific community by patenting the discoveries of UW-Madison researchers and licensing these technologies to leading companies in Wisconsin, the United States and worldwide. In this way, WARF also facilitates the use of UW-Madison research for the maximum benefit of society. WARF distributes the income from commercial licenses to the UW-Madison, the inventors and their departments. Each year, WARF contributes more than $45 million to fund additional UW-Madison research. The university refers to WARF's annual gifts as its "margin of excellence" funding.

Geron Corp. Medical Support Services | Menlo Park, California

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Asterias Biotherapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Asterias Biotherapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Asterias Biotherapeutics, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15